Tag: Synergy

Two further studies support three-month DAPT following PCI

Further evidence for a shorter duration of dual antiplatelet therapy (DAPT) in patients implanted with a drug eluting stent has been provided with the...

TCT 2017: No role for bare metal stents to reduce duration...

Olivier Varenne (Hôpital Cochin, Assistance Publique—Hôpitaux De Paris, Paris, France) reported that the strategy of using bare metal stents to enable a shorter duration...

ESC 2017: Best-practice PCI outperforms conventional PCI in patients with de...

The SYNTAX II study has found that percutaneous coronary intervention (PCI) using state-of-the-art techniques—including physiological assessment and a new-generation drug-eluting stent—significantly reduces the rate...

ADVERT: SYNERGY™

Everolimus-Eluting Platinum Chromium Coronary Stent System Drug Eluting stent technology with durable polymer has shown encouraging efficacy compared to bare metal stents, significantly reducing restenosis...

Contemporary Issues in Complete Revascularisation

  This educational supplement is only for readers in countries outside Europe.  In this educational supplement, sponsored by Boston Scientific, Cardiovascular News explores both complete and...

TCT 2016: All comers study finds no differences between Orsiro, Synergy...

BIO-RESORT, presented at TCT today during a late-breaking trial session, has found no significant differences at one year between Medtronic's Resolute Integrity (a durable...